Abstract
Since the introduction of the total mesorectal excision by Heald, many changes in the therapeutic management of rectal cancer have been incorporated. The multidisciplinary approach to colorectal cancer, integrated in a team of different specialists, ensures individualised treatment for each patient with rectal cancer. Therefore the role of the pathologist has acquired an important relevance, not only in diagnosing but also managing and evaluating the surgical specimen. The knowledge of preoperative staging, distance between tumour and anal verge or in patients subjected to a neoadjuvant treatment is necessary for the pathologist to make a detailed, accurate and good-quality report. Parameters such as the macroscopic quality of the mesorectum, the status of the circumferential resection margin and the lymph node harvest are considered basic criteria recommended by the current guidelines for the multidisciplinary team audit.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Heald RJ (1988) The ‘Holy Plane’ of rectal surgery. J R Soc Med 81:503–508
Landheer ML, Therasse P, van de Velde CJ (2002) The importance of quality assurance in surgical oncology. Eur J Surg Oncol 28:571–602
Church JM, Gibbs P, Chao MW, Tjandra JJ (2003) Optimizing the outcome for patients with rectal cancer. Dis Colon Rectum 46:389–402
Radcliffe A, Brown G (2001) Will MRI provide maps of lines of excision for rectal cancer? Lancet 357:495–496
Nelson H, Sargent DJ (2001) Refining multimodal therapy for rectal cancer. N Engl J Med 345:690–692
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482
Kelly MJ, Lloyd TD, Marshall D et al (2003) A snapshot of MDT working and patient mapping in the UK colorectal cancer centres in 2002. Colorectal Dis 5:577–581
Quirke P (1997) Limitations of existing systems of staging for rectal cancer: the forgotten margin. In: Soreide O, Norstein J; eds. Rectal cancer surgery: optimisation, standardisation, documentation. Springer Verlag, Berlin pp. 63–81
Williams GT, Shepherd NA on behalf of the RCPath Cancer Services Working Group (2007) Dataset for colorectal cancer (2nd edn). The Royal College of Pathologists. Available at www. rcpath.org
Burton S, Brown G, Daniels IR et al (2006) MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer 94:351–357
Cervantes A, Rodriguez-Braun E, Navarro S et al (2007) Integrative decisions in rectal cancer. Ann Oncol 18(Suppl 9):ix127–ix131
Cervantes A, Rosello S, Rodriguez-Braun E et al (2008) Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer. Ann Oncol 19(Suppl 7):vii266–vii272
Salerno G, Daniels IR, Moran BJ et al (2006) Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience. Clin Radiol 61:916–923
Wiggers T (2003) Staging of rectal cancer. Br J Surg 90:895–896
MERCURY Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333:779
Heald RJ, Moran BJ, Ryall RD et al (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133:894–899
Goh V, Halligan S, Bartram CI (2004) Local radiological staging of rectal cancer. Clin Radiol 59:215–226
Hall NR, Finan PJ, al-Jaberi T et al (1998) Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 41:979–983
Arbman G, Nilsson E, Hallbook O, Sjodahl R (1996) Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 83:375–379
Lopez-Kostner F, Lavery IC, Hool GR et al (1998) Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 124:612–617
Heald RJ, Smedh RK, Kald A et al (1997) Abdominoperineal excision of the rectum—an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum 40:747–751
Lavery IC, Lopez-Kostner F, Fazio VW et al (1997) Chances of cure are not compromised with sphincter-saving procedures for cancer of the lower third of the rectum. Surgery 122:779–784
Nagtegaal ID, van de Velde CJ, Marijnen CA et al (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23:9257–9264
den Dulk M, Putter H, Collette L et al (2009) The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer 45:1175–1183
Holm T, Ljung A, Haggmark T (2007) Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 94:232–238
West NP, Finan PJ, Anderin C (2008) Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 26:3517–3522
Quirke P (2003) Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 4:695–702
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999
Nagtegaal ID, van de Velde CJ, van der Worp E (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734
Nagtegaal ID, Marijnen CA, Kranenbarg EK (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357
Hermanek P, Hohenberger W, Klimpfinger M (2003) The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis 18:335–341
Enker WE, Levi GS (2009) Macroscopic assessment of mesorectal excision. Cancer 115:4890–4894
Garcia-Granero E, Faiz O, Munoz E et al (2009) Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. Cancer 115:3400–3411
Chan KW, Boey J, Wong SK (1985) A method of reporting radial invasion and surgical clearance of rectal carcinoma. Histopathology 9:1319–1327
de Haas-Kock DF, Baeten CG, Jager JJ et al (1996) Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 83:781–785
Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707–711
Wibe A, Rendedal PR, Svensson E et al (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327–334
Birbeck KF, Macklin CP, Tiffin NJ et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235:449–457
Ng IO, Luk IS, Yuen ST et al (1993) Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features. Cancer 71:1972–1976
Mekenkamp LJ, van Krieken JH, Marijnen CA et al (2009) Lymph node retrieval in rectal cancer is dependent on many factors-the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol 33(10):1547–1553
Cianchi F, Palomba A, Boddi V et al (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 26:384–389
Kim YW, Kim NK, Min BS (2009) The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg 249:965–972
Kim YW, Kim NK, Min BS et al (2009) The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol 100:1–7
Kerwel TG, Spatz J, Anthuber M et al (2009) Injecting methylene blue into the inferior mesenteric artery assures an adequate lymph node harvest and eliminates pathologist variability in nodal staging for rectal cancer. Dis Colon Rectum 52:935–941
Sobin LH, Fleming ID (1997) TNM classification of malignant tumors, fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80:1803–1804
Sobin LH (2003) TNM, sixth edition: new developments in general concepts and rules. Semin Surg Oncol 21:19–22
Goldstein NS, Turner JR (2000) Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer 88:2228–2238
Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646
Stockholm Rectal Cancer Study Group (1990) Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 66:49–55
Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740
Sebag-Montefiore D (2006) Developments in the use of chemoradiotherapy in rectal cancer. Colorectal Dis 8(Suppl)3:14–17
Marijnen CA, Nagtegaal ID, Klein Kranenbarg E et al (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976–1984
Nagtegaal ID, Marijnen CA, Kranenbarg EK et al (2002) Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 197:20–27
Wheeler JM, Warren BF, Jones AC, Mortensen NJ (1999) Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists. Br J Surg 86:1108–1120
Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23
Quirke P, Morris E (2007) Reporting colorectal cancer. Histopathology 50:103–112
Newland RC, Dent OF, Chapuis PH, Bokey L (1995) Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients. Cancer 76:564–571
Jass JR, Atkin WS, Cuzick J et al (1986) The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 10:437–459
Tsai HL, Chu KS, Huang YH et al (2009) Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 100:736–743
Georgescu SO, Neacsu CN, Vintila D et al (2007) [Long-term results after surgery for colorectal adenocarcinoma, stage I–III. Problems of prognosis]. Rev Med Chir Soc Med Nat Iasi 111:932–939.
Fitzgerald RH Jr (1982) What is the Dukes’ system for carcinoma of the rectum? Dis Colon Rectum 25:474–477
Hase K, Shatney C, Johnson D et al (1993) Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 36:627–635
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Faus, C., Roda, D., Frasson, M. et al. The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment. Clin Transl Oncol 12, 339–345 (2010). https://doi.org/10.1007/s12094-010-0515-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-010-0515-7